Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 3.083% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
[a] CCC1=NN(C(=O)c2cccnc2)C(O)(C(F)(F)F)C1
[b] CC1=NNC(=O)C1CCC(=O)N/N=C(\C)c1ccccc1
[c] C/C(CC(=O)Nc1cccc(Cl)c1Cl)=N\NC(=O)c1ccccc1Br
[d] C[C@H](NC(=O)c1nc[nH]c1C(=O)NCc1ccccc1)C(=O)OCc1ccccc1
[e] CCN(C(=O)CSc1nc2ccc([N+](=O)[O-])cc2s1)C1CCS(=O)(=O)C1
Answer: a. CCC1=NN(C(=O)c2cccnc2)C(O)(C(F)(F)F)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1=NN(C(=O)c2cccnc2)C(O)(C(F)(F)F)C1
CCC1=NN(C(=O)c2cccnc2)C(O)(C(F)(F)F)C1
[3-ethyl-5-hydroxy-5-(trifluoromethyl)-4H-pyrazol-1-yl]-pyridin-3-ylmethanone